Check the progress of MS treatments in clinical trials by searching them by name or using the page tool. We're updating the type of MS filter so it's not working quite right now. Check back soon to see it in action.
Bexarotene is used to treat skin cancer, but was also tested as a treatment for MS in a Phase 2 clinical trial.
The results of this trial showed that bexarotene was able to repair myelin in humans. However, participants in the trial experienced some serious side effects so bexarotene will not be taken forward into a Phase 3 study.
Phenytoin is already used to treat epilepsy. In a phase 2 clinical trial, phenytoin reduced damage to the back of the eye (retina) by 30% compared with placebo. This suggests it could help to protect nerves from damage.